company background image
A166

CORESTEM KOSDAQ:A166480 Stock Report

Last Price

₩11.50k

Market Cap

₩183.0b

7D

0.4%

1Y

-51.7%

Updated

08 Aug, 2022

Data

Company Financials
A166480 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

A166480 Stock Overview

Corestem, Inc., a bio-pharmaceutical company, engages in the development and production of stem cell therapies for the treatment of incurable diseases in South Korea.

CORESTEM Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for CORESTEM
Historical stock prices
Current Share Price₩11,500.00
52 Week High₩24,800.00
52 Week Low₩9,600.00
Beta1.0
1 Month Change6.48%
3 Month Change-13.21%
1 Year Change-51.68%
3 Year Change43.39%
5 Year Change35.29%
Change since IPO-72.36%

Recent News & Updates

Apr 12
Does CORESTEM (KOSDAQ:166480) Have A Healthy Balance Sheet?

Does CORESTEM (KOSDAQ:166480) Have A Healthy Balance Sheet?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Feb 16
If You Had Bought CORESTEM (KOSDAQ:166480) Shares A Year Ago You'd Have Earned 59% Returns

If You Had Bought CORESTEM (KOSDAQ:166480) Shares A Year Ago You'd Have Earned 59% Returns

CORESTEM Inc. ( KOSDAQ:166480 ) shareholders have seen the share price descend 18% over the month. But looking back...

Dec 25
Corestem (KOSDAQ:166480) Has Debt But No Earnings; Should You Worry?

Corestem (KOSDAQ:166480) Has Debt But No Earnings; Should You Worry?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Shareholder Returns

A166480KR BiotechsKR Market
7D0.4%7.4%2.3%
1Y-51.7%-37.6%-22.6%

Return vs Industry: A166480 underperformed the KR Biotechs industry which returned -36.3% over the past year.

Return vs Market: A166480 underperformed the KR Market which returned -23% over the past year.

Price Volatility

Is A166480's price volatile compared to industry and market?
A166480 volatility
A166480 Average Weekly Movement6.4%
Biotechs Industry Average Movement8.3%
Market Average Movement6.5%
10% most volatile stocks in KR Market11.1%
10% least volatile stocks in KR Market3.9%

Stable Share Price: A166480 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: A166480's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200376Kyung-Suk Kimhttps://www.corestem.com

Corestem, Inc., a bio-pharmaceutical company, engages in the development and production of stem cell therapies for the treatment of incurable diseases in South Korea. It offers NEURONATA-R inj, an autologous bone marrow mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis (ALS). The company also engages in the development of various therapy products for the treatment of systemic lupus erythematosus (SLE), multiple system atrophy (MSA), and cerebellar ataxia (CA) diseases.

CORESTEM Inc. Fundamentals Summary

How do CORESTEM's earnings and revenue compare to its market cap?
A166480 fundamental statistics
Market Cap₩182.95b
Earnings (TTM)-₩14.52b
Revenue (TTM)₩34.07b

5.4x

P/S Ratio

-12.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A166480 income statement (TTM)
Revenue₩34.07b
Cost of Revenue₩24.41b
Gross Profit₩9.66b
Other Expenses₩24.18b
Earnings-₩14.52b

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-912.89
Gross Margin28.34%
Net Profit Margin-42.63%
Debt/Equity Ratio41.2%

How did A166480 perform over the long term?

See historical performance and comparison